Sravan Kumar Emany Insider Profile

4 Followers
Sravan Kumar Emany, SVP & CFO at Ironwood Pharma, holds 231.32K shares in Assertio Therapeutics (Ticker: ASRT), holds 320.57K shares in Ironwood Pharma (Ticker: IRWD).
tipranks
Sravan Kumar Emany

Sravan Kumar Emany
Ironwood Pharma (IRWD)
SVP & CFO

Ranked #72,814 out of 99,335 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

-21.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
87.75%
12.25%
A breakdown of Sravan Kumar Emany's holdings

Insider Roles

Ironwood Pharma
(IRWD)
SVP & CFO
Assertio Therapeutics
(ASRT)
Director
Roles that Sravan Kumar Emany holds in companies

Most Profitable Insider Trade

Stock:
Ironwood Pharma
(IRWD)
Rating:Informative Sell
Date:Nov 23, 2022 - Nov 23, 2023
Return:+25.60%
The most profitable trade made by Sravan Kumar Emany

Sravan Kumar Emany's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Ironwood Pharma
May 20, 2024
SVP & CFO
Uninformative Sell
121.38K
$1.53M
Assertio Therapeutics
May 28, 2024
Director
Uninformative Buy
$213.97K
List of latest transactions for each holding click on a transaction to see Sravan Kumar Emany's performance on stock

Sravan Kumar Emany insider profile FAQ

What is the percentage of profitable transactions made by Sravan Kumar Emany?
The percentage of profitable transactions made by Sravan Kumar Emany is 33%.
    What is the average return per transaction made by Sravan Kumar Emany?
    The average return per transaction made by Sravan Kumar Emany is -21.40%.
      What stocks does Sravan Kumar Emany hold?
      Sravan Kumar Emany holds: IRWD, ASRT stocks.
        What was Sravan Kumar Emany’s latest transaction?
        Sravan Kumar Emany latest transaction was an Uninformative Buy of ―.
          What was Sravan Kumar Emany's most profitable transaction?
          Sravan Kumar Emany’s most profitable transaction was an Informative Sell of IRWD stock on November 23, 2022. The return on the trade was 25.60%.
            What is Sravan Kumar Emany's role in Ironwood Pharma?
            Sravan Kumar Emany's role in Ironwood Pharma is SVP & CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.